TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

Sarepta Therapeutics Inc (NASDAQ:SRPT) Investor Investigation Concerning Potential Securities Laws Violations Announced

  • If you purchased shares of Sarepta Therapeutics Inc (NASDAQ:SRPT), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

April 26, 2016 (Update) - On April 25, 2016, Sarepta Therapeutics Inc issued a statemen on the advisory committee outcome for the use of its durg Eteplirsen in the treatment of Duchenne muscular dystrophy. Among other things, Sarepta Therapeutics Inc said that the advisory committee voted 6-7 against the finding of substantial evidence from adequate and well controlled studies that ...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)